Pulmonx (LUNG) Chief Science & Technology Officer Sells 14,245 Shares

What Happened

• Radhakrishnan Srikanth, Pulmonx's Chief Science & Technology Officer, reported four open-market sales on 2026-09-01 totaling 14,245 shares at $2.26 per share for proceeds of $32,193. The individual lots were: 2,643 shares ($5,973), 2,121 shares ($4,793), 3,618 shares ($8,177), and 5,863 shares ($13,250). All transactions are reported as sales (S).

Key Details

• Transaction date: 2026-09-01; Form 4 filed: 2026-09-03 (within the typical 2-business-day filing window).
• Price: $2.26 per share for all lots; total proceeds $32,193.
• Shares owned after transaction: Not specified in the provided Form 4 excerpt.
• Footnotes: Each sale was to cover tax withholding on vested Restricted Stock Units (RSUs):
  • F1: RSUs granted 3/1/2023
  • F2: RSUs granted 3/1/2024
  • F3: RSUs granted 3/3/2025
  • F4: RSUs granted 3/2/2026
• Transaction type: reported as open-market sales to satisfy tax-withholding obligations (routine, tax-related sales).

Context

• These sales were executed to cover tax withholding on vested RSUs (tax-withholding sales are common and are not the same signal as an executive-initiated sale for other reasons). This filing does not indicate an exercise of options or a 10% owner transaction.